Form 4: Alignment Healthcare's Chief Medical Officer, Hyong Kim, Reports Stock Sale

Hyong Kim, Chief Medical Officer of Alignment Healthcare, sold 26,734 shares of common stock at a price of $17.2178 per share on March 20, 2025, according to a Form 4 filing.

Summary

• On March 20, 2025, Hyong Kim, the Chief Medical Officer of Alignment Healthcare, sold 26,734 shares of the company's common stock.
• The sale was executed at a price of $17.2178 per share.
• Following the transaction, Kim directly owns 509,367 shares of Alignment Healthcare.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on September 5, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• Shareholders may interpret the stock sale as a lack of confidence by the Chief Medical Officer, although the sale was conducted under a pre-arranged trading plan.

Key Dates

Keywords

Form 4, Hyong Kim, ALHC, Alignment Healthcare, Stock Sale, Chief Medical Officer, Rule 10b5-1